Skip to main content

Applied DNA Sciences Closes $7.4M Financing Round

NEW YORK, Feb. 15 (GenomeWeb News) - Applied DNA Sciences has raised $7.36 million from a Dec. 30, 2004, stock offering, the Los Angeles-based company said today.


The majority of the funds will be used to "vigorously accelerate" marketing, sales, and distribution programs for the company's DNA-based security products, Applied DNA Sciences said in a statement. The company also said that it will use a portion of the funding to establish a US-based laboratory to produce the security products.


Applied DNA Sciences has raised a total of just over $10 million in venture capital, according to a company spokesperson. In addition, he said that Taiwanese company Biowell has spent approximately $10 million to create the DNA security technology, to which Applied DNA Sciences is in the process of acquiring all rights, title, and interest.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.